Active	Status	Sponsor type	Region	Phase	Filter
22 Active 0 Inactive 22 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hathorne, Heather R
ICoN-1, NCT06418711: Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension	Recruiting	3	234	US	Clofazimine Inhalation Suspension, MNKD-101, Placebo	Mannkind Corporation	MAC Lung Disease, Treatment Refractory MAC Lung Disease, Mycobacterium Infections, Nontuberculous	08/26	12/28
NCT05495243: Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough	Completed	2	40	US	ARINA-1, Placebo	Renovion, Inc.	Non-cystic Fibrosis Bronchiectasis	02/24	02/24
AEROW, NCT05248230: 4D-710 in Adult Patients with Cystic Fibrosis	Recruiting	1/2	40	US	4D-710	4D Molecular Therapeutics	Cystic Fibrosis Lung	12/26	01/30
Solomon, George M
BMX-04-001, NCT05010577 / 2022-003810-35: Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection	Active, not recruiting	1b/2a	32	Europe, US, RoW	BX004-A, Bacteriophage, Placebo, Vehicle buffer	BiomX, Inc., BiomX Ltd.	Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis	10/23	03/24
AEROW, NCT05248230: 4D-710 in Adult Patients with Cystic Fibrosis	Recruiting	1/2	40	US	4D-710	4D Molecular Therapeutics	Cystic Fibrosis Lung	12/26	01/30
HFCWO, NCT04271969: Clinical Effectiveness Of High Frequency Chest Wall Oscillation () In A Bronchiectasis Population	Completed	N/A	25	US	SmartVest Airway Clearance System	Electromed, Inc., University of Alabama at Birmingham	Bronchiectasis	12/23	12/23
Anderson, Justin
NCT05495243: Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough	Completed	2	40	US	ARINA-1, Placebo	Renovion, Inc.	Non-cystic Fibrosis Bronchiectasis	02/24	02/24
AEROW, NCT05248230: 4D-710 in Adult Patients with Cystic Fibrosis	Recruiting	1/2	40	US	4D-710	4D Molecular Therapeutics	Cystic Fibrosis Lung	12/26	01/30